CIRCULATION CONTROL
Print ISSN : 0389-1844
Volume 40, Issue 3
Displaying 1-9 of 9 articles from this issue
  • [in Japanese]
    2019Volume 40Issue 3 Pages 154-156
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Download PDF (1524K)
  • [in Japanese]
    2019Volume 40Issue 3 Pages 157-160
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Download PDF (957K)
  • [in Japanese], [in Japanese], [in Japanese]
    2019Volume 40Issue 3 Pages 161-163
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Download PDF (1784K)
  • [in Japanese], [in Japanese], [in Japanese]
    2019Volume 40Issue 3 Pages 164-166
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Download PDF (2530K)
  • [in Japanese]
    2019Volume 40Issue 3 Pages 167-169
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Download PDF (537K)
  • [in Japanese]
    2019Volume 40Issue 3 Pages 170-173
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Download PDF (1824K)
  • Ryo Yamaguchi, Masanori Yamamoto
    2019Volume 40Issue 3 Pages 174-180
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    In Japan there has been a rapid increase in transcatheter aortic valve implantation (TAVI) patients and centers since the introduction of TAVI into clinical practice on October 2013. TAVI has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis who are at high or prohibitive surgical risk. Surgical aortic valve replacement (SAVR) remains the gold standard for patients at low or intermediate operative risk. However, TAVI has currently emerged as a qualified alternative to SAVR in the treatment of those patients although the long-term durability of TAVI devices remain unanswered. Here, we will focus on the current status and future perspectives for TAVI procedures.
    Download PDF (533K)
  • Jun Shimizu
    2019Volume 40Issue 3 Pages 181-185
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    Life threating complications, like annulus rupture which occurs at transcatheter aortic valve implantation (TAVI), are getting rare these days. As a result of randomized controlled trials, indication of TAVI is expanding to low-risk cases. Survival is now a matter of course; improvement of long-term quality of life after the procedure is the prime focus. To achieve this goal, handling of complications previously regarded as insignificant, like anemia, acute kidney injury, stroke and respiratory dysfunction should be the main stream for management. In this review these new “significant” complications are reviewed.
    Download PDF (770K)
  • Hidekazu Setoguchi, Sinjo Eriko, Ryoko Fujimoto, Jun Maki, Yuji Karash ...
    2019Volume 40Issue 3 Pages 186-189
    Published: 2019
    Released on J-STAGE: December 26, 2019
    JOURNAL FREE ACCESS
    A-57-year-old woman with Eisenmenger’s syndrome due to ASD was underwent cystoscopic biopsy and ureteroscopy under general anesthesia. The patient had been treated with warfarin, PDE 5 inhibitor, endothelin receptor antagonist, and PGI2. The patient was NHYA class 3 due to hypoxemia (SpO2 75% with O2 3 L/min) and right heart failure. Pulmonary vascular resistance revealed very little, if any, response to either one or combination of oxygen and nitric oxide inhalation. To maintain systemic vascular resistance and venous return, general anesthesia was performed with spontaneous breathing using laryngeal mask airway. The perioperative hemodynamics including right-to-left shunt balance was maintained. In anesthetic management in an adult patient with Eisenmenger’s syndrome, general anesthesia with laryngeal mask airway, which can maintain spontaneous ventilation, can be a useful option.
    Download PDF (1055K)
feedback
Top